Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marylyn M Addo

Showing results (131-140 of 183) with videos related to

Pageof 19
Sort By:
Journal of Infection and Public Health|September 23, 2023
Comparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 - A retrospective single-center cohort studyThomas Theo Brehm, Andreas Heyer, Marcel S Woo, et al.
NPJ Vaccines|January 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humansLeonie Mayer, Leonie M Weskamm, Anahita Fathi, et al.
Viruses|August 23, 2020
Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating ImmunoglobulinsTill Koch, Monika Rottstegge, Paula Ruibal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 12, 2021
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant PatientsDarius F Ruether, Golda M Schaub, Paul M Duengelhoef, et al.
Viruses|January 8, 2025
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant RecipientsPhilippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann, et al.
NPJ Vaccines|February 5, 2024
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 conditionClaudia Fischer, Edith Willscher, Lisa Paschold, et al.
Frontiers in Immunology|February 15, 2021
Integrin Alpha E (CD103) Limits Virus-Induced IFN-I Production in Conventional Dendritic CellsVikas Duhan, Vishal Khairnar, Simo Kitanovski, et al.
United European Gastroenterology Journal|March 15, 2022
SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver diseasePaul Duengelhoef, Johannes Hartl, Darius Rüther, et al.
Scientific Reports|March 12, 2021
Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenzaThomas Theo Brehm, Marc van der Meirschen, Annette Hennigs, et al.
Journal of Virology|June 14, 2003
Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequencesMarcus Altfeld, Marylyn M Addo, Raj Shankarappa, et al.
Pageof 19

Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Journal of Infection and Public Health|September 23, 2023
Comparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 - A retrospective single-center cohort studyThomas Theo Brehm, Andreas Heyer, Marcel S Woo, et al.
NPJ Vaccines|January 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humansLeonie Mayer, Leonie M Weskamm, Anahita Fathi, et al.
Viruses|August 23, 2020
Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating ImmunoglobulinsTill Koch, Monika Rottstegge, Paula Ruibal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 12, 2021
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant PatientsDarius F Ruether, Golda M Schaub, Paul M Duengelhoef, et al.
Viruses|January 8, 2025
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant RecipientsPhilippa von der Schulenburg, Georg M N Behrens, Markus Hoffmann, et al.
NPJ Vaccines|February 5, 2024
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 conditionClaudia Fischer, Edith Willscher, Lisa Paschold, et al.
Frontiers in Immunology|February 15, 2021
Integrin Alpha E (CD103) Limits Virus-Induced IFN-I Production in Conventional Dendritic CellsVikas Duhan, Vishal Khairnar, Simo Kitanovski, et al.
United European Gastroenterology Journal|March 15, 2022
SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver diseasePaul Duengelhoef, Johannes Hartl, Darius Rüther, et al.
Scientific Reports|March 12, 2021
Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenzaThomas Theo Brehm, Marc van der Meirschen, Annette Hennigs, et al.
Journal of Virology|June 14, 2003
Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequencesMarcus Altfeld, Marylyn M Addo, Raj Shankarappa, et al.
Pageof 19